Breast Milk Fats and Lipids: Expanding Benefits to Fragile Infant Populations

 

Steven D. Freedman, MD, PhD

Chief of the Division of Translational Research and Professor
of Medicine, Harvard Medical School;
and Director of The Pancreas Center,
Beth Israel Deaconess Medical Center,
Boston, Massachusetts, USA
 

Additional Videos

Guido E. Moro, MD

The history of milk banking: from origin to present time

Guido E. Moro, MD
Stella M. Davies, MBBS, PhD, MRCP

Human milk to prevent and heal gastrointestinal tract injury in children after bone marrow transplantation

Stella M. Davies, MBBS, PhD, MRCP
Edmund La Gamma, MD

Transfusion-related acute gut injury (TRAGI): potential mechanisms and opportunities for prevention

Edmund La Gamma, MD
Mandy Brown Belfort, MD, MPH

Human milk and preterm infant brain development

Mandy Brown Belfort, MD, MPH
Mohammed Ghaly, PhD

Human milk-based industry in the Muslim world: how to address the religio-ethical challenges?

Mohammed Ghaly, PhD
Summary Speaker Bio
Rate this Content 0 Votes

Speaker Bio - Steven D. Freedman, MD, PhD

Dr. Freedman received his PhD from Yale University School of Medicine and his MD from the University of Connecticut. He completed his residency and fellowship in Gastroenterology at Beth Israel Hospital in Boston and has remained on the faculty since 1991. Dr. Freedman has played a leadership role in clinical/translational research at both Beth Israel Deaconess Medical Center and Harvard Medical School through his prior role as the Associate Dean for Clinical and Translational Research and Co-director of the Harvard CTSA (Harvard Catalyst). He is currently Director of the Pancreas Center at Beth Israel Deaconess Medical Center, as well as Chief of the Division of Translational Research and Professor of Medicine at Harvard Medical School. Dr. Freedman’s expertise is in exocrine pancreatic disease with a particular focus on pancreatitis and cystic fibrosis (CF). He is an internationally recognized leader in these areas with an extensive research program that encompasses both basic science discovery and clinical trials.

More recently, Dr. Freedman has expanded these research discoveries to the pathogenesis and treatment of neonatal morbidities. He has also been a leader in identifying the site in the brain where pancreatic visceral pain is represented, has developed molecular signatures of pain using magnetic resonance spectroscopy, and has successfully developed pain therapies using transcranial magnetic stimulation. In addition to this research, Dr. Freedman has developed a major focus on health care delivery reform to improve the doctor-patient relationship, and has an extensive track record on training the next generation of physician scientists. Dr. Freedman has developed and launched a national initiative to train pediatric and adult gastroenterologists across North America in the diagnosis and treatment of the gastrointestinal manifestations of CF (DIGEST), and has extended his training initiatives to include his recent appointment as Director of the Beth Israel Deaconess Medical Center Internal Medicine Residency Physician Scientist Track.